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Supplementary Materials:    
Methodology 
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Introduction 
At the MQ meeting on 9th September 2019 (Edinburgh), we hosted a discussion session, where 
we asked participants how they would envision a National Infrastructure for Mental Health Data 
Science (referred to as “platform” below). Participants were advised that their collected input would 
be fed back to the MRC to serve as a starting point for their full consultation on this topic.  
Key findings 
● Researchers are particularly interested in using such a platform themselves and recognise 
its utility to a large number of other organisations.  
 
● The minimum useful requirement for such a platform is a searchable directory of 
available data with a note about access procedures. Whereas an ideal platform might 
contain the actual data. Our participants demonstrated a wide interest in the inclusion of 
different data types and research areas within such a platform.  
 
● Participants were enthusiastic about the possibilities such a platform might enable, 
mentioning expansion of research topics and conducting more rigorous research. They felt 
the platform might enable this by maximizing data quality/usage and facilitating data 
access.   
 
● Participants recognised the positive impact such a platform could have on people affected 
by mental illness. Patterns of responses arose around patient engagement, policy shaping, 
open science, and improved research quality. All these elements could help fight the 
stigma of mental illness in society. 
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● With regard to the MRC consultation, our participants recognised the need to consult with 
a range of organisations, including data donors, ethical boards, privacy panels and 
relevant charities - with an observed less enthusiastic support for political involvement 
(which may reflect current political circumstances).  
 
● Our participants raised a number of concerns, which the MRC may wish to address 
during their consultation phase. These included long-term sustainability, governance, and 
ethical considerations. On a practical note, questions were raised around prioritization, 
practicalities on data management, platform operation and relevant training and capacity 
building. Lastly, the participants illustrated the need to raise public awareness of and 




Q1-Q4: Multiple Choice 
 
 




 Public Health bodies nationally and internationally 
 The Public  
 Patients, carers and their charities 
 A range of other private companies 
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2) In addition to those listed in the last question: Who else should be consulted 









Additional Response: How can it be linked to other datasets?  
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4) What is the minimum the platform would need to contain, for it to be useful to 




5) What kind of data should it contain/link to? (multiple answers permitted)  
 
Additional Responses: 
 Prescribing data and wider social determinants of health 
 Environment, social data, adversity 
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Q6-Q7: Free Text 
Note:  
1. The examples are not direct quotes. They were drawn from the free text answers and reconsolidated to 
avoid repetition and improve readability. 
2. The categories are not paralleled, and some may have crossover coverage. 
 
6) What research would an ‘ideal’ platform allow you to conduct, which is not possible 
now?   
Category Examples 
Maximizing data usage 
- Improved data linkage (e.g. ability to describe full clinical pathway) 
- Increased breadth of variables 
- Availability for re-use by others 
- Improved meta-data 
- Collation of research outputs 
Broadening data capacity & 
accessibility 
- Single site for multi-data sources 
- Allowing for interoperability 
- Augmentation of current data sets 
Expanding research topics 
- Coverage of minority or vulnerable groups (e.g. research around 
social deprivation and disparities) 
- Prediction analysis for scenario planning (e.g. effect of Brexit on 
prescription drug availability) 
- Ability to do research across datasets (e.g. genetic, imaging) and 
across disorders 
- If there is access to consolidated research outputs, better 
opportunities for collaboration between research groups and 
expansion of peer work 
- Ability to detect rare outcomes (nationwide coverage) 
- Incidence cohorts with follow up at scale 
Conducting more rigorous 
research 
- Using synthetic data to make an analysis plan before research 
design/ application for funding  
- Hypothesis Testing (e.g. how would this population manage without 
treatment, how would they respond to various interventions). 
- Reassurance that clinically relevant research is conducted with the 
right cohorts and therefore, is representative of the population 
- Due to improved data linkage, ability to better understand clinical 
pathways and how/where relevance of data lies 
 
Improving data quality 
- Reduction of bias in relation to gaps in data 
- Allowing for nationwide coverage (e.g. clinical and census data) 
- Harmonization of codes and outcome measures, making the 
available info more searchable 
- Primary to secondary care – where have patients interacted with 
health system, and outputs of that.  
- How many people actually accessing CAMS? 
- Secondary care prescribing – hard to access/can’t find it. Collected 
by commercial companies – filling the gaps?  
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How can we maximize the platforms positive impact on people affected by mental illness?  
 
Category Examples 
Impact/change to relevant 
policies 
- By sharing outcomes of research based on data available from 
platform (e.g. to specialists, policy makers and the public)  
- By including James Lind Alliance Priority Setting Partnership 
results 
Engage with patients & 
carers 
- Increase of public awareness about available data, relevant 
research, intervention options, and how their data is used 
- Integration of engagement with patients and relevant stakeholders 
all throughout the research  
- By working with patients to increase engagement (e.g. loading up 
own graph and data) 
Make it available for open 
science & public 
- Obligation for open access publishing 
- Obligation to share methodologies 
- Registering protocols – eg for observational data, hub for learning, 
like clinical trials registry 
- Possibility for access for researchers worldwide 
- Links to biographies / communities of interest so the public can 
connect into research and build confidence in participating 
- Allow public access so the public can see descriptive results from 
each research output 
- Ensuring transparency in data we use 
Improve research quality 
- Establishment of feedback loops with NHS data coders 
- By implementing science through building on new insights derived 
from research done with this data 
- Possibility to contact researchers for clarification of findings 
Tackle sociological issues - Help fight stigma of mental illness 
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- How to develop a specialized workforce for this platform? Further 
to that question, how can the MRC support career development for 
analysts in order to minimize disruption? (e.g. fixed term contracts 
will not be sustainable) 
- How to learn from best practices from other nations? (e.g. Iceland, 
Norway) 
- How to project and analyze for the future? Further to that question 
what will the platform look like in 20 years? 
- How to integrate user feedback in order to improve the platform? 
- How to plan for when technical infrastructure becomes obsolete? 
How can it be extended, how can it be gracefully retired and can 
some parts be used in other platforms / projects? 
Qualification & training 
- For the people using the platform 
- For the people inputting the data 
- Linking to PhD training via Doctoral Training Partnerships e.g. 
Horizon, ATI 
Data management 
- How to harmonize data across locations? 
- If / how to brainstorm with other (commercial) organizations (e.g. 
Tesco club card, razor database)? How to potentially link this 
data? 
- How to amplify relevance for existing datasets to be shared by 
researchers and participants? 
- How to manage research reproducibility with data from the 
platform? 
- How to make data that is donated to the platform citable? 
Prioritization 
- How to prioritize the different project brief elements? 
- Will the MRC try to encompass all possibilities or try to find a 
specific focus? 
- What can be achieved within a given time frame? 
- Should it be considered to start small (with a good “spine” of 
phenotype data) vs huge dataset with potentially large 
discrepancies in quality? (e.g. go small with higher levels of limited 
success vs going big and falling short) 
Platform operation 
- Requirement to think of branding on both mental health and data 
platform sides 
- Design of incentive scheme for data collectors 
Governance & security 
- Who would be responsible for this platform? 
- Who would benefit from the platform? 
- Who would get access?  (e.g. which organizations) 
- Approvals process for access – single point of approval would be 
desirable e.g. institutional 
- How will access be determined e.g. cost 
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- Clear, straightforward, timely process for data access.  
- What about considerations on standards of security? (also on 
international level) 
- How to deal with different governance standards for different data? 
- How to give people access to and control over their data? (e.g. 
learnings from care data) 
- Could a cross-council initiative help maximize limited resources in 
mental health? 
- How to ensure the governance policy of data access fore-sight 
enough? 
Ethical considerations 
- How to organize the process of getting consent (improve public 
perceptions) 
- How to integrate moral and ethical thinking into platform access 
requirements. 
- Data availability & purpose planning 
- Should there be incentives for researchers who collected the data? 
- How do critics of big data anticipate the potential misuse. (e.g. 
concerns of parents) 
- Consideration of planning for opt in / opt out option for children 
reaching adulthood 
- Consideration of permission and consent for mental health data 
collection and how it can impact research 
- How to address public fears on data use including re-identification? 
Raise public awareness & 
involvement 
- How can the platform be used to address mental health mis-reports 
on media? 
- How can it be used to increase the level of public understanding of 
genetics and their impact? 
- How can it be used to encourage the public to contribute? 
- Close engagement with patient/service user groups 
- Make decisions together with the communities 
- Under-represented participants – research needs here – may be 
different requirements.  
 
 
Public Engagement Benefit 
A national platform such as this could reduce the need for repeated public 
consultations. 
As it stands, individual groups of researchers carry out their own engagement activities with 
reference to their own specific research interests.  
A national platform such as this, could undertake large scale public consultations, to 
elucidate public opinion on research. These are likely to be more accurate (i.e. larger and 
more representative) and more cost effective in terms of time, effort and resources. The 
results could then be shared within the platform for use by multiple researchers (e.g. on their 
ethics and public benefit forms).  




Our participants showed great enthusiasm for a national platform for Mental Health Data 
Science and could see many ways in which it would be beneficial to both researchers and a 
wide range of other stakeholders. However, they did express some practical and ethical 
concerns and agreed that a wider consultation was necessary.    
 
 
Supplementary Materials:  
 
Methodology 
The MQ meeting participants were mental health data science researchers from various 
universities and organisations across the UK.   
 
During the discussion session, the participants were asked to form groups (referred to as 
“respondents” below) in order to answer the survey collectively and anonymously. The facilitators 
suggested that the participants move away from their immediate colleagues or friends to avoid 
bias.  
 
Groups received the survey questions as both paper handouts and on the main screen.  
Responses were collected through a dedicated webpage on Aha Slides, accessed via specific 
browser link or QR code.  
 
Questions 1 - 5 were multiple choice questions, with questions 3 and 4 permitting only one answer. 
Questions 6-8 were open-ended questions. 
 
The results were collected and analysed by the knowledge exchange team in Mental Health Data 
Science Scotland, under the guidance of Dr Iona Beange. 
 
The graphs were created on excel, while the qualitative input was categorized into central themes 
to facilitate reading. 
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List of Questions  
A snapshot of the questions, responses and respondent figures can be found in the table below. 














1) Who would have an 
interest in using it? 
- Researchers 
- Funders 
- Medical / pharma companies 
- Computing / informatics / 
programming companies 
- Clinicians 
- Health baords 
- NHS trusts 
- Governments 
- Other (collected with post-its) 
46 255 yes 
Multiple 
Choice 
2) Who else should be 
consulted? (in addition 
to those listed in the 
last question)  
- People whose data will be included 
(e.g. NHS users, cohort members) 
- Charities 
- Politicians 
- Public benefit & privacy panels 
- Ethics boards 
- Other (collected with post-its) 
49 154 yes 
Multiple 
Choice 
3) What would the 
ideal platform contain?  
- Actual downloadable data 
- Actual data, that is analysed within 
the platform (without downloading) 
- A searchable directory of potentially 
available data, with a note about 
access procedures 
- Other (collected with post-its) 
51 51 no 
Multiple 
Choice 
4) What is the 
minimum the platform 
would need to contain, 
for it to be useful to 
you? 
48 48 no 
Multiple 
Choice 
5) What kind of data 
should it contain/link 
to? 
- Genetic / genomic / epigenetic data 
- Brain imaging data (e.g. MRI) 
- Phenotypic data (incl. Diet, smoking, 
alcohol consumption) 
- Cognitive ability data 
- Data linkage (e.g. to health records, 
admin data sets like census, 
prescription data) 
- Data from people with a mental 
health diagnosis 
- Population-wide data (e.g. incl. 
“Healthy” individuals) 
- Other (collected with post-its) 
50 289 yes 
Open 
Ended 
6) What research 
would an 'ideal' 
platform allow you to 
conduct, which is not 
possible now?  
n/a 12 24 yes 




7) How can we 
maximize the 
platforms positive 
impact on people 
affected by mental 
illness? 
15 31 yes 
Open 
Ended 
8) What other 
questions do the MRC 
need to ask during the 
scoping / consultation 
phase? 
12 36 yes 
 
[END report] 
 
